Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS

Area of Science:

• Neuroimmunology
• Genetics
• Cellular Pathology

Background:

• Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system (CNS).
• Current immunomodulatory therapies often fail to prevent progressive disability due to impaired myelin regeneration and neuronal loss.
• This highlights the need to explore additional cellular pathologies beyond the immune system.

Purpose of the Study:

• To develop a general approach for identifying specific cell types where disease alleles contribute to pathology.
• To apply this method to Multiple Sclerosis (MS) risk loci to pinpoint pathogenic cell types.
• To investigate novel cellular mechanisms and therapeutic targets in MS.

Main Methods:

• Developed a novel computational approach to attribute MS risk loci to specific cell types.
• Applied the approach to a large set of MS genetic risk loci.
• Conducted functional studies on oligodendrocyte maturation and transcriptional regulation.

Main Results:

• Identified likely pathogenic cell types for 70% of MS risk loci.
• Discovered myeloid- and CNS-specific risk loci, including those affecting oligodendrocyte transcriptional pause release.
• Demonstrated that impaired transcriptional elongation blocks oligodendrocyte maturation and is dysregulated in MS brain tissue.

Conclusions:

• MS pathogenesis involves cell-intrinsic aberrations in non-immune cells, particularly oligodendrocytes.
• Dysregulation of transcriptional pause release in oligodendrocytes is a key pathway in MS.
• These findings suggest new therapeutic strategies targeting oligodendrocyte-intrinsic pathways for MS treatment.